title: The ocular surface epithelial barrier and other mechanisms of mucosal protection: from allergy to infectious diseases.
abstract: OBJECTIVE
  Studies completed in the last decade provide new insights into the role of the epithelial glycocalyx in maintaining ocular surface barrier function. This review summarizes these findings, their relevance to allergic and infectious disease, and highlights the potential benefits of exploiting the modulation of barrier integrity for therapeutic gain.
  
  
  RESULTS
  The molecular components sealing the space between adjacent ocular surface epithelial cells, such as tight junctions, have been extensively characterized, and their contribution to the paracellular barrier established. A second layer of protection - the transcellular barrier - is provided by transmembrane mucins and their O-glycans on the glycocalyx. Cell surface glycans bind carbohydrate-binding proteins to promote formation of complexes that are no longer thought to be a static structure, but, instead, a dynamic system that responds to extrinsic signals and modulates pathogenic responses. Although functioning as a protective mechanism to maintain homeostasis, the glycocalyx also restricts drug targeting of epithelial cells.
  
  
  CONCLUSIONS
  The traditional model of intercellular junctions protecting the ocular surface epithelia has recently been expanded to include an additional glycan shield that lines apical membranes on the ocular surface. A better understanding of this apical barrier may lead to better management of ocular surface disease.
authors: IRCCS Fodazione G. B. Bietti of Rome, Italy.
authors: Flavio
authors: F
authors: Mantelli
authors: Jerome
authors: J
authors: Mauris
authors: Pablo
authors: P
authors: Argüeso
mesh_terms: D000818:Animals; D003228:Conjunctiva / Q000276:immunology; D019573:Epithelium, Corneal / Q000276:immunology*; D005123:Eye / Q000276:immunology* / Q000473:pathology; D005128:Eye Diseases / Q000276:immunology; D019276:Glycocalyx / Q000276:immunology*; D006706:Homeostasis; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology*; D018928:Immunity, Mucosal; D007239:Infections / Q000276:immunology*; D009077:Mucins / Q000276:immunology; D019108:Tight Junctions / Q000276:immunology
chemical_list: D009077:Mucins
references: J Immunol. 2004 Aug 1;173(3):1902-7
references: 15265923
references: Infect Immun. 1997 Jul;65(7):2747-53
references: 9199445
references: Dev Biol. 1983 Apr;96(2):337-45
references: 6403397
references: Invest Ophthalmol Vis Sci. 2000 Dec;41(13):4080-4
references: 11095599
references: Nat Rev Immunol. 2008 Mar;8(3):205-17
references: 18301424
references: Invest Ophthalmol Vis Sci. 2009 Sep;50(9):4060-4
references: 19420336
references: Cell. 1996 Feb 9;84(3):381-8
references: 8608591
references: Invest Ophthalmol Vis Sci. 2001 Oct;42(11):2483-9
references: 11581187
references: Invest Ophthalmol Vis Sci. 1998 Dec;39(13):2602-9
references: 9856770
references: Curr Opin Allergy Clin Immunol. 2008 Oct;8(5):477-83
references: 18769205
references: Curr Eye Res. 1986 Aug;5(8):601-9
references: 3093151
references: Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4509-18
references: 17898272
references: Nat Rev Mol Cell Biol. 2001 Apr;2(4):285-93
references: 11283726
references: Allergy. 2008 Oct;63(10):1324-34
references: 18782111
references: Am J Physiol. 1998 Jan;274(1):F1-9
references: 9458817
references: Cutan Ocul Toxicol. 2009;28(3):93-103
references: 19505226
references: Allergy. 2011 Jul;66(7):919-24
references: 21261658
references: Am J Ophthalmol. 2003 Aug;136(2):318-26
references: 12888056
references: Br J Ophthalmol. 2006 Sep;90(9):1208-9
references: 16929070
references: Curr Opin Allergy Clin Immunol. 2007 Oct;7(5):424-8
references: 17873583
references: Biochem Biophys Res Commun. 2012 Jul 20;424(1):12-7
references: 22683626
references: Surv Ophthalmol. 1997 Nov-Dec;42(3):233-46
references: 9406369
references: Invest Ophthalmol Vis Sci. 2006 Feb;47(2):541-4
references: 16431948
references: Ophthalmology. 1997 Feb;104(2):223-35
references: 9052626
references: Graefes Arch Clin Exp Ophthalmol. 2012 Aug;250(8):1169-80
references: 22527325
references: Pharm Res. 2012 Aug;29(8):2329-40
references: 22565639
references: Invest Ophthalmol Vis Sci. 2005 Feb;46(2):703-8
references: 15671302
references: Macromol Biosci. 2011 Jun 14;11(6):748-64
references: 21188688
references: J Pharm Sci. 2008 May;97(5):1652-80
references: 17828745
references: Infect Immun. 2008 Nov;76(11):5215-20
references: 18794288
references: Ther Deliv. 2010 Sep;1(3):435-56
references: 21399724
references: Clin Transl Allergy. 2011 Jun 10;1(1):5
references: 22410284
references: Eur J Ophthalmol. 2009 Nov-Dec;19(6):916-22
references: 19882588
references: PLoS One. 2012;7(3):e32418
references: 22412870
references: J Biol Chem. 2009 Aug 21;284(34):23037-45
references: 19556244
references: Annu Rev Microbiol. 2001;55:407-35
references: 11544362
references: Infect Immun. 1994 May;62(5):1799-804
references: 8168942
references: Prog Retin Eye Res. 2003 Mar;22(2):113-33
references: 12604055
references: Invest Ophthalmol Vis Sci. 2000 Apr;41(5):961-4
references: 10752928
references: Cornea. 2005 Nov;24(8 Suppl):S18-S23
references: 16227818
references: Br J Ophthalmol. 2001 Nov;85(11):1336-40
references: 11673302
references: Invest Ophthalmol Vis Sci. 2003 Jan;44(1):86-92
references: 12506059
references: Exp Eye Res. 1997 Jan;64(1):11-20
references: 9093016
references: J Biol Chem. 2004 Mar 19;279(12):10841-7
references: 14672941
references: Invest Ophthalmol Vis Sci. 2004 Jul;45(7):2212-7
references: 15223797
references: Exp Eye Res. 2003 Jun;76(6):663-9
references: 12742348
references: Chem Immunol Allergy. 2006;90:91-112
references: 16210905
references: Crit Rev Ther Drug Carrier Syst. 1999;16(1):85-146
references: 10099899
references: Clin Exp Allergy. 2006 Dec;36(12):1556-65
references: 17177679
references: Invest Ophthalmol Vis Sci. 2011 Jul 29;52(8):5641-6
references: 21508102
references: J Virol. 2013 May;87(10):5841-7
references: 23487460
references: Invest Ophthalmol Vis Sci. 2009 Jun;50(6):2666-72
references: 19011014
references: Invest Ophthalmol Vis Sci. 1999 Jun;40(7):1328-35
references: 10359313
references: Graefes Arch Clin Exp Ophthalmol. 2007 Jun;245(6):899-902
references: 17120009
references: Drug Dev Ind Pharm. 2002 Apr;28(4):353-69
references: 12056529
references: Br J Ophthalmol. 1998 Jul;82(7):797-800
references: 9924375
references: Invest Ophthalmol Vis Sci. 2011 Mar 28;52(3):1762-9
references: 21051695
references: Annu Rev Microbiol. 1989;43:503-36
references: 2508540
references: Nat Rev Microbiol. 2009 Jun;7(6):424-38
references: 19444247
references: J Allergy Clin Immunol. 2011 Sep;128(3):549-56.e1-12
references: 21752437
references: J Biol Chem. 2002 Nov 1;277(44):42299-305
references: 12194966
references: Mucosal Immunol. 2013 Mar;6(2):379-92
references: 22929560